Cite
HARVARD Citation
Heinzerling, L. et al. (2021). Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'. European journal of cancer. pp. 272-273. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Heinzerling, L. et al. (2021). Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'. European journal of cancer. pp. 272-273. [Online].